Evidence map›Paper›PMID 37069199›Full record

Trial reportScientific reports2023

Health economic evaluation of a randomized controlled trial (EMBLA study), an internet-based treatment for provoked vulvodynia.

A Hess Engström, N Bohm-Starke, M Buhrman, U Högberg, A Skalkidou, S Lagenskiöld

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

A Hess EngströmDepartment of Women's and Children's Health, Uppsala University, BOX 593, 751 24, Uppsala, Sweden. andrea.hess.engstrom@kbh.uu.se.
N Bohm-StarkeDivision of Obstetrics and Gynecology, Department of Clinical Sciences, Karolinska Institute, Solna, Sweden.
M BuhrmanDivision Clinical Psychology, Department of Psychology, Uppsala University, Uppsala, Sweden.
U HögbergDepartment of Women's and Children's Health, Uppsala University, BOX 593, 751 24, Uppsala, Sweden.
A SkalkidouDepartment of Women's and Children's Health, Uppsala University, BOX 593, 751 24, Uppsala, Sweden.
S LagenskiöldDepartment of Medical Sciences, Uppsala University, Uppsala, Sweden.
Uppsala University · SEKarolinska Institutet · SEMälardalen University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Internet-based treatment (IBT) for provoked vulvodynia (PVD) may reduce pain during intercourse and increases pain acceptance. However, a there is still a knowledge gap regarding the cost-effectiveness of IBT for PVD. The aim of this study was to perform a health economic evaluation of guided internet-based intervention for PVD as an addition to standard treatment. The sample consisted of 99 women with a PVD diagnosis. Healthcare related costs, health-related quality of life, and quality-adjusted life-years (QALYs) and incremental cost-effectiveness ratio (ICER) were analyzed. After the IBT, the intervention group had fewer visits to a midwife than the control group (p = 0.03), but no between-group differences were found for visits to other professionals, treatment length, health-related quality of life, QALYs, and costs for treatment. It was estimated a cost of 260.77 € for a clinical meaningful change in pain acceptance. Internet-based treatment as add-on to clinical treatment may lower number of visits to a healthcare.

Indexed as

Quality of LifeVulvodyniaCost-Benefit AnalysisFemaleHumansInternetPain

Identifiers

PMID37069199
PMCPMC10110522
OpenAlexW4366178719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.